R&D Systems™ Recombinant Human vWF-A2 Protein, CF

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 2764WF050

Catalog No. 2764WF050

Description

Measured by its ability to be used as a protein substrate for ADAMTS13. >50% of rhvWF-A2 is cleaved as measured under the described conditions.

Specifications

• Accession Number: NP_000543
• Formulation: Supplied as a 0.2 µm filtered solution in Tris, NaCl and Glycerol.
• Molecular Weight (g/mol): M.W. (Observed): 18 kDa, reducing conditions; M.W. (theoretical): 20 kDa
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Source: E. coli-derived human vWF-A2 protein Asp1498-Val1665, with an N-terminal Met and 6-His tag
• Endotoxin Concentration: <1.0 EU / 1 µg of the protein by the LAL method.
• Conjugate: Unconjugated
• Protein: vWF-A2

• For Use With (Application): Enzyme Activity
• Gene ID (Entrez): 7450
• Name: vWF-A2
• Quantity: 50 µg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 3 months, -20°C to -70°C under sterile conditions after opening.
• Gene Symbol: VWF
• Recombinant: Yes